Jill Turner

2.3k total citations
72 papers, 1.8k citations indexed

About

Jill Turner is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Jill Turner has authored 72 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 29 papers in Cellular and Molecular Neuroscience and 14 papers in Oncology. Recurrent topics in Jill Turner's work include Nicotinic Acetylcholine Receptors Study (26 papers), Receptor Mechanisms and Signaling (17 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). Jill Turner is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (26 papers), Receptor Mechanisms and Signaling (17 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). Jill Turner collaborates with scholars based in United States, Canada and United Kingdom. Jill Turner's co-authors include Julie A. Blendy, Kenneth J. Kellar, Laura M. Castellano, Paul R. Bierman, Pavel I. Ortinski, Alberta A. Davis, M Nachtigal, Paul S. Bernstein, Dean Bok and Richard C. Hunt and has published in prestigious journals such as The Lancet, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Jill Turner

71 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill Turner United States 26 926 548 210 201 160 72 1.8k
Yuichiro Watanabe Japan 25 642 0.7× 545 1.0× 195 0.9× 156 0.8× 293 1.8× 110 2.2k
Paul J. Gasser Switzerland 29 747 0.8× 580 1.1× 238 1.1× 289 1.4× 136 0.8× 79 2.7k
Consuelo Walss‐Bass United States 29 886 1.0× 379 0.7× 120 0.6× 280 1.4× 213 1.3× 108 2.6k
Bradley T. Webb United States 27 1.2k 1.3× 556 1.0× 99 0.5× 325 1.6× 409 2.6× 86 3.3k
Nina Mononen Finland 30 954 1.0× 176 0.3× 134 0.6× 198 1.0× 100 0.6× 88 2.4k
Ran Tao United States 27 2.2k 2.3× 367 0.7× 90 0.4× 265 1.3× 307 1.9× 110 3.4k
Yota Fujimura Japan 22 497 0.5× 449 0.8× 211 1.0× 372 1.9× 139 0.9× 62 2.0k
Thomas Bettecken Germany 22 786 0.8× 163 0.3× 155 0.7× 255 1.3× 204 1.3× 53 2.0k
María J. Arranz United Kingdom 35 1.2k 1.3× 1.3k 2.4× 112 0.5× 310 1.5× 455 2.8× 113 4.2k

Countries citing papers authored by Jill Turner

Since Specialization
Citations

This map shows the geographic impact of Jill Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Turner more than expected).

Fields of papers citing papers by Jill Turner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Turner. The network helps show where Jill Turner may publish in the future.

Co-authorship network of co-authors of Jill Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Turner. A scholar is included among the top collaborators of Jill Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Turner. Jill Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Dan, Michael D. Sunshine, Jill Turner, et al.. (2024). Targeting α1- and α2-adrenergic receptors as a countermeasure for fentanyl-induced locomotor and ventilatory depression. Environmental Toxicology and Pharmacology. 110. 104527–104527. 2 indexed citations
2.
Turner, Jill, et al.. (2024). Distinct 5-HT receptor subtypes regulate claustrum excitability by serotonin and the psychedelic, DOI. Progress in Neurobiology. 240. 102660–102660. 5 indexed citations
3.
O’Donovan, Bernadette, et al.. (2024). Dynamic effects of ventral hippocampal NRG3/ERBB4 signaling on nicotine withdrawal-induced responses. Neuropharmacology. 247. 109846–109846. 3 indexed citations
4.
Anderson, E. L., et al.. (2022). Age‐specific impacts of nicotine and withdrawal on hippocampal neuregulin signalling. European Journal of Neuroscience. 56(6). 4705–4719. 4 indexed citations
5.
Kumar, Mohit, Jennifer R. Rainville, Joshua A. Lile, et al.. (2021). Sexually dimorphic neuroimmune response to chronic opioid treatment and withdrawal. Neuropharmacology. 186. 108469–108469. 16 indexed citations
6.
O’Donovan, Bernadette, et al.. (2019). Altered gating of Kv1.4 in the nucleus accumbens suppresses motivation for reward. eLife. 8. 25 indexed citations
7.
Galloway, Ashley L., Sherine S.L. Chan, Michael D. Wyatt, et al.. (2019). Microglia morphology and proinflammatory signaling in the nucleus accumbens during nicotine withdrawal. Science Advances. 5(10). eaax7031–eaax7031. 74 indexed citations
8.
Millman, Roanne, et al.. (2019). Patient interest in the Lowdown on Down There: attendance at a vulvovaginal and sexual health workshop post-cancer treatment. Supportive Care in Cancer. 28(8). 3889–3896. 7 indexed citations
9.
Walker, Lauren M., Ericka Wiebe, Jill Turner, et al.. (2019). The Oncology and Sexuality, Intimacy, and Survivorship Program Model: An Integrated, Multi-disciplinary Model of Sexual Health Care within Oncology. Journal of Cancer Education. 36(2). 377–385. 13 indexed citations
10.
Turner, Jill, Karen Chu, Fleur Huang, et al.. (2019). Informal caregiver quality of life in a palliative oncology population. Supportive Care in Cancer. 28(4). 1695–1702. 24 indexed citations
11.
Galloway, Ashley L., Bernadette O’Donovan, C.N.R. Rao, et al.. (2018). Dopamine Triggers CTCF-Dependent Morphological and Genomic Remodeling of Astrocytes. Journal of Neuroscience. 38(21). 4846–4858. 24 indexed citations
12.
Turner, Jill, et al.. (2018). An Essential Postdevelopmental Role for Lis1 in Mice. eNeuro. 5(1). ENEURO.0350–17.2018. 10 indexed citations
13.
Vassoler, Fair M., et al.. (2016). Transgenerational attenuation of opioid self-administration as a consequence of adolescent morphine exposure. Neuropharmacology. 113(Pt A). 271–280. 48 indexed citations
14.
Loukola, Anu, et al.. (2015). Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-morbid Disorders. International review of neurobiology. 124. 113–131. 9 indexed citations
15.
Turner, Jill, Laurel E. Ecke, Lisa A. Briand, Philip G. Haydon, & Julie A. Blendy. (2012). Cocaine-related behaviors in mice with deficient gliotransmission. Psychopharmacology. 226(1). 167–176. 36 indexed citations
16.
Portugal, George S., Derek S. Wilkinson, Jill Turner, Julie A. Blendy, & Thomas J. Gould. (2012). Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning. Neurobiology of Learning and Memory. 97(4). 482–494. 67 indexed citations
17.
Balu, Darrick T., Jill Turner, Bethany R. Brookshire, et al.. (2012). Brain monoamines and antidepressant-like responses in MRL/MpJ versus C57BL/6J mice. Neuropharmacology. 67. 503–510. 9 indexed citations
18.
Turner, Jill, Pavel I. Ortinski, Rachel M. Sherrard, & Kenneth J. Kellar. (2011). Cerebellar Nicotinic Cholinergic Receptors are Intrinsic to the Cerebellum: Implications for Diverse Functional Roles. The Cerebellum. 10(4). 748–757. 15 indexed citations
19.
Nekolaichuk, Cheryl, et al.. (2010). Referral patterns and psychosocial distress in cancer patients accessing a psycho‐oncology counseling service. Psycho-Oncology. 20(3). 326–332. 56 indexed citations
20.
Turner, Jill, Laura M. Castellano, & Julie A. Blendy. (2010). Parallel Anxiolytic-Like Effects and Upregulation of Neuronal Nicotinic Acetylcholine Receptors Following Chronic Nicotine and Varenicline. Nicotine & Tobacco Research. 13(1). 41–46. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026